Enrico Martin

287 General discussion and future perspectives 33. Tokumoto H, Akita S, Kubota Y, Kuriyama M, Mitsukawa N. Use of Vascularized Sural Nerve Grafts for Sciatic Nerve Reconstruction After Malignant Bone and Soft Tissue Tumor Resection in the Lower Legs. Ann Plast Surg . 2018;80(4):379-383. doi:10.1097/SAP.0000000000001315 34. Costales JR, Socolovsky M, Sanchez Lazaro JA, Alvarez Garcia R. Peripheral nerve injuries in the pediatric population: a review of the literature. Part I: traumatic nerve injuries. Childs Nerv Syst . 2019;35(1):29-35. doi:10.1007/s00381-018- 3974-8 35. Park JW, Kim H-S, Yun JY, Han I. Neuropathic pain after sarcoma surgery: Prevalence and predisposing factors. Medicine (Baltimore) . 2018;97(21):e10852. doi:10.1097/MD.0000000000010852 36. Eberlin KR, Ducic I. Surgical Algorithm for Neuroma Management: A Changing Treatment Paradigm. Plast Reconstr surgery Glob open . 2018;6(10):e1952. doi:10.1097/ GOX.0000000000001952 37. Pasquali S, Colombo C, Pizzamiglio S, et al. High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial. Eur J Cancer . 2018;93:28-36. doi:10.1016/j.ejca.2018.01.071 38. van Praag VM, Rueten-Budde AJ, Jeys LM, et al. A prediction model for treatment decisions in high-grade extremity soft- tissue sarcomas: Personalised sarcoma care (PERSARC). Eur J Cancer . 2017;83:313- 323. doi:10.1016/j.ejca.2017.06.032 39. Raut CP, Callegaro D, Miceli R, et al. Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG. Clin Cancer Res . 2019;25(8):2664-2671. doi:10.1158/1078-0432.CCR-18-2700 40. Tan MCB, Brennan MF, Kuk D, et al. Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma. Ann Surg . 2016;263(3):593-600. doi:10.1097/SLA.0000000000001149 41. Brekke HR, Kolberg M, Skotheim RI, et al. Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors. Neuro Oncol . 2009;11(5):514-528. doi:10.1215/15228517-2008-127 42. Cleven AHG, Sannaa GA Al, Briaire- de Bruijn I, et al. Loss of H3K27 tri- methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival. Mod Pathol . 2016;29(6):582-590. doi:10.1038/modpathol.2016.45 12